Don't be caught off-guard: Clorox CLX releases its next round of earnings this Thursday.
Want to skip the homework and get all the facts in one place? We thought so. Here is your everything-that-matters guide for Thursday's Q4 earnings announcement before the bell
Earnings and Revenue
Sell-side analysts expect Clorox's EPS to be near $1.57 on sales of $1.72 billion.
In the same quarter last year, Clorox posted EPS of $1.53 on sales of $1.65 billion. The Wall Street estimate would represent a 2.61 percent increase in the company's earnings. Sales would be up 4.43 percent from the year-ago period. Here's how the company's reported EPS has compared to analyst estimates in the past:
Quarter | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 |
EPS Estimate | 1.31 | 1.23 | 1.41 | 1.49 |
EPS Actual | 1.37 | 1.16 | 1.46 | 1.53 |
Stock Performance
Over the last 52-week period, shares are up 1.81 percent. Given that these returns are generally positive, long-term shareholders can be satisfied going into this earnings release. Analyst estimates are adjusted higher for EPS and revenues over the past 90 days. Analysts seem to have settled on a Sell rating with Clorox. The strength of this rating has maintained conviction over the past three months.
Conference Call
Clorox's Q4 conference call is scheduled to begin at 1:30 p.m. ET and can be accessed here: https://investors.thecloroxcompany.com/investors/news-and-events/events-and-presentations/default.aspx
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.